迈得医疗2月2日获融资买入929.92万元，融资余额6966.36万元

Group 1 - The core viewpoint of the news is that Maide Medical has shown a stable performance in terms of financing and stockholder changes, indicating a solid position in the medical equipment industry [1][2]. Group 2 - As of February 2, Maide Medical's stock price increased by 0.61%, with a trading volume of 95.09 million yuan. The financing buy-in amount was 9.29 million yuan, while the financing repayment was 8.92 million yuan, resulting in a net financing buy of 0.38 million yuan [1]. - The total financing and securities balance for Maide Medical reached 69.66 million yuan, accounting for 2.56% of its circulating market value, which is above the 70th percentile level over the past year [1]. - The company has not engaged in any short selling activities on February 2, with a short selling balance of 0.00 yuan, indicating a high level of confidence among investors [1]. Group 3 - As of September 30, the number of shareholders for Maide Medical increased to 4,528, a rise of 19.00%, while the average circulating shares per person decreased by 15.97% to 36,709 shares [2]. - For the period from January to September 2025, Maide Medical reported a revenue of 225 million yuan, reflecting a year-on-year growth of 2.31%, and a net profit attributable to shareholders of 8.84 million yuan, which is a 15.82% increase compared to the previous year [2]. - The company has distributed a total of 202 million yuan in dividends since its A-share listing, with 99.30 million yuan distributed over the last three years [2]. Group 4 - Among the top ten circulating shareholders as of September 30, 2025, Huaxia Industry Prosperity Mixed Fund (003567) is the fourth largest with 2.60 million shares, having decreased its holdings by 1.07 million shares. New entrants include the交银稳健配置混合 (519690) and 交银科技创新灵活配置混合A (519767) [2].